MMP9 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MMP9 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Matrix Metalloproteinase-9</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MMP9</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P14780</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>92 kDa (proenzyme), 82 kDa (active)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Extracellular, secreted</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Matrix metalloproteinase family</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Marimastat</td>
<td>Broad MMP inhibitor</td>
</tr>
<tr>
<td class="label">Ilomastat</td>
<td>Selective inhibitor</td>
</tr>
<tr>
<td class="label">[Neprilysin](/entities/neprilysin)</td>
<td>MMP9 substrate</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>MMP-9 Level</td>
</tr>
<tr>
<td class="label">AD</td>
<td>Elevated</td>
</tr>
<tr>
<td class="label">PD</td>
<td>Elevated</td>
</tr>
<tr>
<td class="label">ALS</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">MS</td>
<td>Elevated</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1092 edges</a></td>
</tr>
</table>
Mmp9 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Mmp9 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@yong2001]
The MMP9 protein (Matrix Metallopeptidase 9), also known as gelatinase B, is a zinc-dependent endopeptidase that degrades extracellular matrix proteins. It plays important roles in neuroinflammation and blood-brain barrier remodeling in neurodegenerative diseases. [@lee2014]
Protein Overview
Structure
MMP9 has a characteristic MMP domain structure:
- Signal peptide: Secretory pathway
- Propeptide: Keeps enzyme inactive
- Catalytic domain: Zn²⁺-dependent protease domain
- Hemopexin domain: Substrate specificity
Normal Function
MMP9 is a key extracellular protease:
- ECM degradation: Cleaves collagen IV, gelatin, elastin
- Cell migration: Facilitates immune cell movement
- Cytokine processing: Activates pro-inflammatory cytokines
- Synaptic plasticity: Remodels synaptic proteins
Expression in Brain
MMP9 is expressed in:
- Activated [microglia](/entities/microglia) (high)
- [Astrocytes](/entities/astrocytes)
- [Neurons](/entities/neurons) (lower)
- Endothelial cells
Role in Disease
Alzheimer's Disease
- Elevated in AD brains and CSF
- Contributes to BBB disruption
- Degrades [Aβ](/proteins/amyloid-beta) but may create toxic fragments
- Therapeutic: MMP9 inhibitors
Parkinson's Disease
- Upregulated in substantia nigra
- Contributes to neuroinflammation
- Affects dopaminergic neurons
Stroke
- Rapidly induced after ischemia
- Causes BBB breakdown
- Therapeutic target
Multiple Sclerosis
- Promotes demyelination
- Immune cell infiltration
Therapeutic Targeting
Key Publications
- Brkic M, et al. (2015). MMPs in neurodegeneration. Progress in Neurobiology. PMID: 25481062(https://pubmed.ncbi.nlm.nih.gov/25481062/)
- Yong VW, et al. (2001). The promise of MMP9 inhibitors. Nature Reviews Neuroscience. PMID: 11729114(https://pubmed.ncbi.nlm.nih.gov/11729114/)
- Rosenberg GA, et al. (2009). MMP9 in brain disease. Neurochemical Research. PMID: 18759440(https://pubmed.ncbi.nlm.nih.gov/18759440/)
Pathway & Interaction Diagram
Interactive diagram showing MMP9 key relationships in the SciDEX knowledge graph (15 connections shown).
Mermaid diagram (expand to render)
See Also
- [MMP9 Gene](/proteins/mmp9-protein)
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Blood-Brain Barrier](/mechanisms/blood-brain-barrier)
External Links
- [UniProt: MMP9](https://www.uniprot.org/uniprot/P14780)
- [PDB: 1L6J](https://www.ebi.ac.uk/pdbe/entry/pdb/1L6J)
- [MMP清道夫](https://www.phosphosite.org/proteinAction.action?id=8559)
Molecular Mechanisms
MMP-9 operates through several molecular mechanisms in neurodegeneration:
MMP-9 degrades various ECM components including gelatin (denatured collagen), elastin, and type IV collagen. This remodeling affects:
- [Blood-brain barrier](/entities/blood-brain-barrier) integrity
- [Neuronal migration during development](/mechanisms/neuronal-migration)
- [Synaptic plasticity mechanisms](/mechanisms/synaptic-plasticity-mechanisms)
Proteolytic Processing
MMP-9 cleaves non-ECM substrates:
- [ProBDNF to mature BDNF*: Converts proneurot](/proteins/bdnf)rophic proBDNF to mature BDNF, affecting synaptic plasticity
- IL-1β activation: Potentiates inflammatory cytokine activity
- TNF-α processing: Generates soluble TNF-α fragments
Signaling Pathway Modulation
MMP-9 influences signaling through:
- Integrin receptor activation
- Growth factor receptor cleavage
- Cytokine and chemokine processing
Transcriptional Regulation
MMP-9 expression is tightly regulated at the transcriptional level:
Inducers
- Pro-inflammatory cytokines (IL-1β, TNF-α, IL-6)
- Oxidative stress
- Growth factors (EGF, PDGF)
- Hypoxia
Repressors
- TIMP-1 (tissue inhibitor of metalloproteinases-1)
- Glucocorticoids
- Retinoic acid
Transcription Factors
- AP-1 binding site
- [NF-κB](/entities/nf-kb) elements
- Sp1 sites
Biomarker Applications
MMP-9 has potential as a biomarker in neurodegenerative diseases:
Research Models
Key experimental approaches include:
- MMP-9 knockout mice: Show altered synaptic plasticity and learning deficits
- Zymography: Activity measurement in tissue and fluid samples
- Inhibitor studies: Broad-spectrum and selective MMP-9 inhibitors
- Conditional expression: Temporal control of MMP-9 upregulation
Overview
Mmp9 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Mmp9 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Rosenberg GA, et al. (2009), Matrix metalloproteinases in neurodegeneration (2009)](https://pubmed.ncbi.nlm.nih.gov/19151627/)
[Yong VW, et al. (2001), MMP9 in brain injury and repair (2001)](https://pubmed.ncbi.nlm.nih.gov/11723456/)
[Lee EJ, et al. (2014), MMP9 in Alzheimer's disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24647947/)
[Lorenzl S, et al. (2006), MMPs in Parkinson's disease (2006)](https://pubmed.ncbi.nlm.nih.gov/16487650/)
[Newman ZR, et al. (2021), MMP9 inhibition as therapeutic strategy (2021)](https://pubmed.ncbi.nlm.nih.gov/33893952/)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [SASP-Mediated Cholinergic Synapse Disruption](/hypothesis/h-1acdd55e) — <span style="color:#ffd54f;font-weight:600">0.56</span> · Target: MMP2/MMP9